Supplementary Table 8 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
Year: 2026
Type: supplementary-materials
Abstract: Clinical characteristics of patients who received preoperative lenvatinib treatment
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7204999941
